Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
RESOLVE-IT Failure Dashes Genfit's NASH Hopes
Elafibranor Missed Trial Endpoints At The Interim Stage
May 12 2020
•
By
Sten Stovall
RESOLVE-IT missed its primary endpoint for treating NASH • Source: Shutterstock
More from Clinical Trials
More from R&D